Eledon Pharmaceuticals (ELDN) Research & Development (2016 - 2017)
Historic Research & Development for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q1 2017 value amounting to $306000.0.
- Eledon Pharmaceuticals' Research & Development fell 9614.17% to $306000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $17.4 million, marking a year-over-year decrease of 4202.27%. This contributed to the annual value of $52.0 million for FY2024, which is 7143.05% up from last year.
- Eledon Pharmaceuticals' Research & Development amounted to $306000.0 in Q1 2017, which was down 9614.17% from $1.0 million recorded in Q4 2016.
- In the past 5 years, Eledon Pharmaceuticals' Research & Development registered a high of $10.6 million during Q1 2015, and its lowest value of $306000.0 during Q1 2017.
- Moreover, its 4-year median value for Research & Development was $5.9 million (2015), whereas its average is $5.6 million.
- As far as peak fluctuations go, Eledon Pharmaceuticals' Research & Development skyrocketed by 20056.64% in 2015, and later plummeted by 9614.17% in 2017.
- Quarter analysis of 4 years shows Eledon Pharmaceuticals' Research & Development stood at $3.8 million in 2014, then soared by 103.29% to $7.7 million in 2015, then plummeted by 86.6% to $1.0 million in 2016, then plummeted by 70.46% to $306000.0 in 2017.
- Its Research & Development was $306000.0 in Q1 2017, compared to $1.0 million in Q4 2016 and $6.2 million in Q3 2016.